IDHIFA® For Relapsed / Refractory Acute Myeloid Leukemia
Learn more about IDHIFA® (enasidenib) for patients with relapsed/refractory acute myeloid leukemia (AML) with an IDH2 mutation. See safety info and BOXED WARNING on …
About IDHIFA® and How It Works | Patient Site
What is IDHIFA ® and what is an IDH2 mutation? IDHIFA ® is an oral prescription medicine used to treat people with AML with an IDH2 mutation whose disease has come back or has not …
IDHIFA® is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not …
¿Qué es IDHIFA® (enasidenib)? IDHIFA® es un medicamento con receta que se utiliza para tratar a personas con leucemia mieloide aguda (LMA) con una mutación en el gen isocitrato …
IDHIFA® (enasidenib) es un medicamento con receta que se usa para tratar a personas con leucemia mieloide aguda (LMA) con una mutación de la isocitrato dehidrogenasa-2 (IDH2) …
IDHIFA® (enasidenib) is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or …
¿Qué es IDHIFA? IDHIFA® (enasidenib) es un medicamento de venta con prescripción utilizado para el tratamiento de la leucemia mielógena aguda (AML, por sus siglas en inglés) en …
IDHIFA® (enasidenib) is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or …
IDHIFA®es un medicamento recetado que se usa para tratar a personas con leucemia mieloide aguda (LMA) con una mutación de isocitrato deshidrogenasa-2 (isoocitrate dehydrogenase-2, …
As a caregiver, you have the important and often challenging role of providing emotional and physical support for someone with relapsed/refractory AML. Whether you are caring for a …